Revolutionizing Cancer Treatment with CaperRX Inc.
PRODUCT DEVELOPMENT
Why is it so difficult to kill cancer cells?
Cancer survives through mutations that make the cancer resistant to killing.
Caper is an essential cancer mutation protein that activates cancer defense mechanisms that are present on cancer DNA.
Caper acts a spark plug to activate cancer protective survival mechanisms at the DNA level by binding to the cancer AP1 complex involved in tumor growth and survival.
Caper is essential to maintain the ability of cancer to survive. Inhibition of caper results in cancer death.
Our lead peptide (CAPER-003) inhibition of caper leads to cancer cell death without effect on normal cells.
Efficient cancer kill will result in significantly improved quality of life and survival of cancer patients.
MECHANISM OF ACTION
First-in-class novel proprietary peptides that block CAPER (co-activator of AP1 and Estrogen receptor) as a fundamental universal cancer treatment targeting cancer mutation proteins (AP1 complex) necessary for cancer survival.
THERAPEUTIC ADVANTAGE
Killing Cancer by inhibiting caper is fundamentally overriding cancer mutations that make cancer resistant to immune defense and therapeutic treatments.
Cancer despite oncotype, that are expressing caper are susceptible to inhibition with our peptides leading to cancer cell death.
Caper cancer oncoprotein is observed in numerous cancers including breast, glioblastoma, colorectal and lung.
Off target side effects of inhibition by selective peptides for caper should be limited due to the high specificity for this caper cancer activator protein.
(215) 669-7591
